Journey Medical Corp
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.3% | -108.3% | -38.5% | -34.8% | -7.9% | 16.3% | -21.6% | -6.3% | -13.5% | -39.1% | 18.2% | -9.4% | -11.0% | |
| 2.4% | 5.5% | 6.4% | 5.6% | 5.7% | 7.4% | 8.3% | 7.2% | 6.2% | 6.8% | 7.2% | 5.2% | 6.3% | |
| 1.6% | 3.5% | 10.8% | 11.3% | 11.2% | 10.1% | 10.1% | 8.9% | 10.5% | 11.0% | 6.2% | 7.8% | 8.9% | |
| 1.2% | -102.8% | 23.9% | -30.5% | -6.0% | -10.7% | -11.1% | 5.0% | -18.2% | -49.6% | 18.0% | -31.1% | -20.6% | |
| 0.0% | 32.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | 32.8% | – | – | – | -110.1% | – | – | – | – | – | – | – | |
| – | – | – | – | -4.6% | 90.3% | -4.8% | 0.0% | 0.0% | 101.7% | 0.0% | 0.0% | 24.0% | |
| -31.8% | 125.9% | 12.6% | 33.9% | -2.0% | 78.0% | 27.4% | 1.1% | 39.9% | 33.7% | 1.4% | 0.9% | 18.8% | |
| 22.5% | 17.6% | -26.0% | -1.0% | -9.9% | -15.8% | 5.8% | -5.2% | 26.4% | -5.3% | 19.6% | -8.5% | 7.8% | |
| 54.3% | -108.3% | -38.5% | -34.8% | -7.9% | 16.3% | -21.6% | -6.3% | -13.5% | -39.1% | 18.2% | -9.4% | -11.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.